Xylanase and β-Xylosidase from Penicillium janczewskii: Production, Physico-Chemical properties, and application of the crude extract to pulp biobleaching

Extracellular xylanase and β-xylosidase production by a Penicillium janczewskii strain were investigated in liquid cultures with xylan from oat spelts under different physical and chemical conditions. The selected conditions for optimized production of xylanase and β-xylosidase were 7 days, pH 6.5, at 30 °C and 8 days, pH 5.0, at 25 °C, respectively. The xylanase exhibited optimal activity in pH 5.0 at 50 °C and the β- xylosidase in pH 4.0 at 75 °C. The xylanase was more stable at pH 6.0 to 9.5, while the β-xylosidase remained stable at pH ranging from 1.6 to 5.5. The xylanase half-life (T50) at 40, 50, and 60 °C was 183, 15, and 3 min, respectively. β-xylosidase half-life was 144, 8, and 4 min at 50, 65, and 75 °C, respectively. When applied to the biobleaching of Eucalyptus kraft pulp, xylanase dosages of 2 and 4 U/g dried pulp reduced, respectively, kappa number by 3.0 and 3.3 units after 1 h treatment, demonstrating that the use of P. janczewskii xylanases in this process is quite promising. The pulp viscosity was not altered, confirming the absence of cellulolytic enzymes in the fungal extract.

Pharmacokinetic Profile of A New Diclofenac Prodrug without Gastroulcerogenic Effect

Gastrotoxicity is a major problem for long-term therapy with non-steroidal anti-inflammatory drugs (NSAIDs). DICCIC (1-(2,6-dichlorophenyl)indolin-2-one) is a new diclofenac prodrug, which has proven anti-inflammatory activity without gastroulcerogenic effect. The aim of this work was to compare the pharmacokinetic profiles of diclofenac from DICCIC (7.6 mg/kg equivalent to 8.1 mg/kg diclofenac) and diclofenac (8.1 mg/kg) administration in Wistar rats weighing 250-300 g (n=20). The doses were calculated by interspecific allometric scaling based on the 2 mg/kg from diary human dose of diclofenac. Blood samples were collected in heparinized tubes via the femoral artery through the implanted catheter. The plasma was separated and quantitation was made in a HPLC system with a UV-Vis detector. The confidence limits of the bioanalytical method were appropriate for its application in a preclinical pharmacokinetic study. The AUC of diclofenac from DICCIC (53.7± 5.8 ug/mL.min) was significantly less (Mann Whitney test, p<0.05) than that of diclofenac from diclofenac administration (885.9 ± 124,8 ug/mL.min). Terminal half-life of diclofenac from DICCIC (50.1 ± 17.2 min) was significantly less (Mann Whitney test, p<0.05) than that of diclofenac from diclofenac administration (247.4 ± 100.9 min). Still the parameters clearance and distribution volume were calculated for diclofenac from diclofenac, whose results were 9.2 ±1.2 mL/min.kg and 3.3 ±1.2 L/kg, respectively. The results of DICCIC from DICCIC administration were 108.9 ± 19.6 mL/min.kg and 7.8 ± 2.4 L/kg for clearance and distribution volume, respectively. The pharmacokinetic profile demonstrated that there was an increase in diclofenac elimination and a lower exposure to diclofenac with administration of DICCIC compared to diclofenac. © 2013 Bentham Science Publishers.

Heavy Mesons Spectroscopy

In this paper, Lippmann-Schwinger equation is solved by using Martin and Cornel potentials to calculate bc̄ energy levels. The results for some energy levels which are not observable, such as those of tt̄ in its short half-life are also predicted. Our calculated energy levels are in good agreement with results of other groups. The stability interval for Yukawa-Linear potential is also studied by investigating the spectrum of eigenvalues. © 2013 Springer Science+Business Media New York.

Proposta de metodologia para o gerenciamento de fonte radioativa e estimativa de dose efeiva em pacientes submetidos à terapia com iodeto de sódio I-131

Pós-graduação em Pesquisa e Desenvolvimento (Biotecnologia Médica) - FMB

Produção e caracterização de glucoamilases termoestáveis de Aspergillus awamori obtidas por PCR mutagênico e expressas em Saccharomyces cerevisiae

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Aspectos farmacológicos da cetamina S(+) associada ou não ao midazolam, em cães

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Estudo comparativo entre heparina sódica e heparina de baixo peso molecular (nadroparina cálcica) em cães (Canis familiaris) submetidos à hemódialise

Pós-graduação em Medicina Veterinária - FMVZ

Farmacocinética pré-clínica do hidroximetilnitrofural (NFOH) – potencial pró-fármaco antichagásico

Pós-graduação em Ciências Farmacêuticas - FCFAR

Uso do Rad7 para a caracterização do torônio em águas de estâncias hidrominerais

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Caracterização radiométrica e de exalação de Radônio em rochas ornamentais silicáticas beneficiadas no Estado do Espírito Santo

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

A correlação da expressão do gene p53 no carcinoma invasor de colo uterino com fatores clínicos e prognóstico

Pós-graduação em Ginecologia, Obstetrícia e Mastologia - FMB

Avaliação metabólica de dietas de C3 e C4 na formação do ovo (gema e albúmen) pelo uso da técnica dos isótopos estáveis do carbono

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Análise químico-farmacêutica de preparações injetáveis de celftriaxona sódica

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Farmacocinética pré-clínica do composto 1-(2,6-diclorofenil)indolin-2-ona (DICCIC), pró-fármaco de diclofenaco

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Turnover do δ13C em sangue e ovo de codorna japonesa na fase de crescimento e postura

Pós-graduação em Zootecnia - FMVZ